Michael V. Knopp

The Ohio State University Wexner Medical Center

Also affiliated with The Ohio State University, University of Cincinnati, University of Cincinnati Medical Center

MedicineMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.406Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Initial reporting from the prospective National Cancer Institute (NCI) COVID-19 in Cancer Patients Study (NCCAPS).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6565

Top 45%

0.406DataRank

Top 45%5 citations

Ana F. Best, Sacha Gnjatic, Andrea Denicoff, Grace Mishkin, Melissa Bowman +15 more

Papers

Driven by 17 papers — median percentile 27. Top paper: “Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial”.

Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial

Blood(2020)10.1182/blood.2019003277

N/A

3.7DataRank · unranked

95 citations

Mei‐Yin C. Polley, Michael V. Knopp, Nathan C. Hall, Lale Kostakoglu, Jun Zhang +14 more

Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors

New England Journal of Medicine(2024)10.1056/nejmoa2403991

N/A

3.0DataRank · unranked

141 citations

Susan M. Geyer, Tyler Zemla, Michael V. Knopp, Spencer C. Behr, Sydney Pulsipher +19 more

Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma

Cancer Discovery(2021)10.1158/2159-8290.cd-21-1141

N/A

0.700DataRank · unranked

105 citations

Megan Othus, Sapna P. Patel, Ahmad A. Tarhini, Vernon K. Sondak, Michael V. Knopp +26 more

Eccentric rehabilitation induces white matter plasticity and sensorimotor recovery in chronic spinal cord injury

Experimental Neurology(2021)10.1016/j.expneurol.2021.113853

N/A

0.505DataRank · unranked

28 citations

Bimal Lakhani, Petra Schmalbrock, Michael V. Knopp, Keith R. Lohse, John L. K. Kramer +10 more

LBA53 Alliance A021602: Phase III, double-blinded study of cabozantinib versus placebo for advanced neuroendocrine tumors (NET) after progression on prior therapy (CABINET)

Annals of Oncology(2023)10.1016/j.annonc.2023.10.047

N/A

0.500DataRank · unranked

27 citations

Susan M. Geyer, F-S. Ou, Michael V. Knopp, Spencer C. Behr, Tyler Zemla +14 more

Harnessing imaging tools to guide immunotherapy trials: summary from the National Cancer Institute Cancer Imaging Steering Committee workshop

The Lancet Oncology(2023)10.1016/s1470-2045(22)00742-2

N/A

0.489DataRank · unranked

25 citations

Heiko Schöder, Elad Sharon, Jedd D. Wolchok, Michael V. Knopp, Richard L. Wahl +18 more

Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study

The Oncologist(2020)10.1634/theoncologist.2020-0039

N/A

0.406DataRank · unranked

14 citations

Daniel G. Stover, Maryam B. Lustberg, Abigail B. Shoben, Meng Zhao, Ewa Mrózek +23 more

Initial reporting from the prospective National Cancer Institute (NCI) COVID-19 in Cancer Patients Study (NCCAPS).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6565

Top 45%

0.406DataRank

Top 45%5 citations

Ana F. Best, Sacha Gnjatic, Andrea Denicoff, Grace Mishkin, Melissa Bowman +15 more

Is local review of positron emission tomography scans sufficient in diffuse large B‐cell lymphoma clinical trials? A CALGB 50303 analysis

Cancer Medicine(2023)10.1002/cam4.5628

N/A

0.320DataRank · unranked

5 citations

Levi Pederson, Michael V. Knopp, David Poon, Jun Zhang, Brad S. Kahl +10 more

Reproducibility of proton density fat fraction assessment of thigh muscle in a multi-site, multi-vendor cohort study at 10 years after anterior cruciate ligament reconstruction

Quantitative Imaging in Medicine and Surgery(2024)10.21037/qims-24-287

N/A

0DataRank · unranked

3 citations

Sibaji Gaj, Richard Lartey, Mei Li, Jeehun Kim, Carl S. Winalski +17 more

Predictive Modeling for Voxel-Based Quantification of Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma (PDAC): A Multi-Institutional Study

Cancers(2020)10.3390/cancers12123656

N/A

0DataRank · unranked

19 citations

L. Widmann, Annie Dai, Kevin Sun, Jie Zhang, Jun Zhao +13 more

Eccentric-focused rehabilitation promotes myelin plasticity in individuals with chronic, incomplete spinal cord injury

medRxiv(2020)10.1101/2020.04.27.20079970

N/A

0DataRank · unranked

1 citations

Bimal Lakhani, Hanwen Liu, Huyen Nguyen, Petra Schmalbrock, Michael V. Knopp +6 more

Discordance between central versus local response assessments in neuroendocrine tumor (NET) patients (pts) enrolled in A021202.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.361

Top 100%

0DataRank

Top 100%0 citations

Michelle R. Mahoney, Timothy R. Asmis, Nathan C. Hall, Sanja Karovic, Michael V. Knopp +9 more

Multi-vendor multi-site quantitative MRI analysis of cartilage degeneration 10 Years after anterior cruciate ligament reconstruction: MOON-MRI protocol and preliminary results

Osteoarthritis and Cartilage(2022)10.1016/j.joca.2022.08.006

N/A

0DataRank · unranked

13 citations

Jeff Murray, Richard Lartey, Sibaji Gaj, J. Kim, Mei Li +14 more

The association of FDG PET/CT and NaF PET/CT with survival outcomes in patients (pts) with metastatic genitourinary malignancies (mGU) treated with cabozantinib + nivolumab +/- ipilimumab (CaboNivo +/- Ipi).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.452

N/A

0DataRank · unranked

0 citations

Katherine Lei, Nicholas Peter Verdini, Jeffrey Lin, Andy Vega, Scot A. Niglio +13 more

Data from Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma

(2023)10.1158/2159-8290.c.6549583.v1

N/A

0DataRank · unranked

0 citations

Megan Othus, Sapna P. Patel, Ahmad A. Tarhini, Vernon K. Sondak, Michael V. Knopp +26 more

FDG PET/CT and NaF PET/CT imaging quantification of osseous metastatic lesions in patients with metastatic genitourinary (mGU) cancer and their association with survival outcomes.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e16573

N/A

0DataRank · unranked

0 citations

Nicholas I. Simon, Elias Chandran, Katherine Lei, Nicholas Peter Verdini, Jeffrey Lin +15 more

Michael V. Knopp

Indexed papers

Top data-sharing exemplar

Papers